The prevalence of Parkinson's disease: A systematic review and meta-analysis, Mov. Disord, vol.29, pp.1583-1590, 2014. ,
, Synucleinopathy phenotypes, vol.20, pp.62-67, 2014.
Parkinson's Disease: Biomarkers, Treatment, and Risk Factors, Front. Neurosci, vol.12, p.612, 2018. ,
beta-Synuclein reduces proteasomal inhibition by alpha-synuclein but not gamma-synuclein, J. Biol. Chem, vol.280, pp.7562-7569, 2005. ,
Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson's Disease, Curr. Neuropharmacol, vol.14, pp.238-249, 2016. ,
Selective autophagy as a potential therapeutic target for neurodegenerative disorders, Lancet Neurol, vol.17, pp.802-815, 2018. ,
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, vol.276, pp.2045-2047, 1997. ,
Riess, O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease, Nat. Genet, vol.18, pp.106-108, 1998. ,
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia, Ann. Neurol, vol.55, pp.164-173, 2004. ,
E46K Mutant alpha-Synuclein Is Degraded by Both Proteasome and Macroautophagy Pathway, Molecules, vol.23, 2018. ,
A30P mutant alpha-synuclein impairs autophagic flux by inactivating JNK signaling to enhance ZKSCAN3 activity in midbrain dopaminergic neurons, Cell Death Dis, vol.10, p.133, 2019. ,
Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy, J. Biol. Chem, vol.286, pp.10814-10824, 2011. ,
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology, Neuron, vol.44, pp.601-607, 2004. ,
LRRK2 pathobiology in Parkinson's disease, J. Neurochem, vol.131, pp.554-565, 2014. ,
LRRK2 G2019S as a Cause of Parkinson's Disease in North African Arabs, N. Engl. J. Med, vol.354, pp.422-423, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00221453
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase, Nat. Genet, vol.38, pp.1184-1191, 2006. ,
A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonism, PLoS ONE, vol.7, 2012. ,
The genetics of Parkinson disease, Ageing Res. Rev, vol.42, pp.72-85, 2018. ,
, Mov. Disord, vol.30, pp.273-278, 2015.
Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: Evidence for variable homozygous deletions in the Parkin gene in affected individuals, Ann. Neurol, vol.44, pp.935-941, 1998. ,
Point Mutations (Thr240Arg and Ala311Stop) in theParkinGene, Biochem. Biophys. Res. Commun, vol.249, pp.754-758, 1998. ,
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism, Nature, vol.392, pp.605-608, 1998. ,
Deletions in the Parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson's disease, Hum. Genet, vol.103, pp.424-427, 1998. ,
Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism, Lancet, vol.352, pp.1355-1356, 1998. ,
Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27, Am. J. Hum. Genet, vol.60, pp.588-596, 1997. ,
Localization of a Novel Locus for Autosomal Recessive Early-Onset Parkinsonism, PARK6, on Human Chromosome 1p35-p36, Am. J. Hum. Genet, vol.68, pp.895-900, 2001. ,
PARK6 is a common cause of familial parkinsonism, Neurol. Sci, vol.23, pp.117-118, 2002. ,
Park6-linked parkinsonism occurs in several european families, Ann. Neurol, vol.51, pp.14-18, 2002. ,
, Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism, vol.299, pp.256-259, 2003.
Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36, Am. J. Hum. Genet, vol.69, pp.629-634, 2001. ,
Gaucher disease: Mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA), Hum. Mutat, vol.29, pp.567-583, 2008. ,
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease, Brain, vol.132, pp.1783-1794, 2009. ,
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease, N. Engl. J. Med, vol.361, pp.1651-1661, 2009. ,
Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease, vol.140, pp.3191-3203, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01690979
Apoptosis and Autophagy in Nigral Neurons of Patients with Parkinson's Disease, Histol. Histopathol, vol.12, pp.25-31, 1997. ,
Chaperone-mediated autophagy markers in Parkinson disease brains, Arch. Neurol, vol.67, pp.1464-1472, 2010. ,
Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease, Neurobiol. Dis, vol.43, pp.690-697, 2011. ,
Pathogenic lysosomal depletion in Parkinson's disease, J. Neurosci, vol.30, pp.12535-12544, 2010. ,
Localization of MAP1-LC3 in Vulnerable Neurons and Lewy Bodies in Brains of Patients With Dementia With Lewy Bodies, J. Neuropathol. Exp. Neurol, vol.70, pp.264-280, 2011. ,
Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy, PLoS ONE, vol.5, 2010. ,
Alteration of autophagosomal proteins in the brain of multiple system atrophy, Neurobiol. Dis, vol.49, pp.190-198, 2013. ,
Involvement of macroautophagy in multiple system atrophy and protein aggregate formation in oligodendrocytes, J. Mol. Neurosci, vol.47, pp.256-266, 2012. ,
Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration, Proc. Natl. Acad. Sci, vol.109, pp.9611-9616, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01290058
Immunolocalization of influenza A virus and markers of inflammation in the human Parkinson's disease brain, PLoS ONE, vol.6, 2011. ,
Autophagy dysfunction in peripheral blood mononuclear cells of Parkinson's disease patients, Neurosci. Lett, vol.704, pp.112-115, 2019. ,
Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease, Nat. Neurosci, vol.18, pp.826-835, 2015. ,
Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions, Neurobiol. Dis, vol.35, pp.385-398, 2009. ,
ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies, Acta Neuropathol. Commun, 2011. ,
Activation and alteration of lysosomes in multiple system atrophy, Neuroreport, vol.23, pp.270-276, 2012. ,
Mitochondrial Dysregulation and Impaired Autophagy in iPSC-Derived Dopaminergic Neurons of Multiple System Atrophy, Stem Cell Rep, vol.11, pp.1185-1198, 2018. ,
Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease, Mov. Disord, vol.30, pp.1639-1647, 2015. ,
Immunohistochemical localization of aggresomal proteins in glial cytoplasmic inclusions in multiple system atrophy, Neuropathol. Appl. Neurobiol, vol.38, pp.559-571, 2012. ,
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains, Ann. Neurol, vol.72, pp.455-463, 2012. ,
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies, Mol. Neurodegener, vol.10, 2015. ,
Reduced glucocerebrosidase is associated with increased alpha-synuclein in sporadic Parkinson's disease, Brain, vol.137, pp.834-848, 2014. ,
Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease, Mov. Disord, vol.22, pp.1481-1484, 2007. ,
Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease, Mov. Disord, vol.29, pp.1019-1027, 2014. ,
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease, Mov. Disord, vol.28, pp.747-754, 2013. ,
Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway, Autophagy, vol.8, pp.754-766, 2012. ,
Deficiency of ATP13A2 leads to lysosomal dysfunction, alpha-synuclein accumulation, and neurotoxicity, J. Neurosci, vol.32, pp.4240-4246, 2012. ,
Increased lysosomal exocytosis induced by lysosomal Ca(2+) channel agonists protects human dopaminergic neurons from alpha-synuclein toxicity, J. Neurosci, 2019. ,
Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice, Sci. Rep, 2018. ,
Rubinsztein, D.C. ?-Synuclein Is Degraded by Both Autophagy and the Proteasome, J. Biol. Chem, vol.278, pp.25009-25013, 2003. ,
Clearance of ?-Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway, J. Neurosci, vol.24, 1888. ,
Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases, J. Neurosci, vol.29, pp.13578-13588, 2009. ,
Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein, Am. J. Pathol, vol.175, pp.736-747, 2009. ,
Impaired Degradation of Mutant ?-Synuclein by Chaperone-Mediated Autophagy, Science, vol.305, p.1292, 2004. ,
Lysosomal degradation of alpha-synuclein in vivo, J. Biol. Chem, vol.285, pp.13621-13629, 2010. ,
Wild type alpha-synuclein is degraded by chaperonemediated autophagy and macroautophagy in neuronal cells, J. Biol. Chem, vol.283, pp.23542-23556, 2008. ,
Impairment of chaperone-mediated autophagy induces dopaminergic neurodegeneration in rats, Autophagy, vol.12, pp.2230-2247, 2016. ,
Influence of microRNA deregulation on chaperone-mediated autophagy and alpha-synuclein pathology in Parkinson's disease, Cell Death Dis, 2013. ,
Targeted suppression of chaperone-mediated autophagy by miR-320a promotes alpha-synuclein aggregation, Int. J. Mol. Sci, vol.15, pp.15845-15857, 2014. ,
DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation, PLoS Biol, 2004. ,
DJ-1 Inhibits alpha-Synuclein Aggregation by Regulating Chaperone-Mediated Autophagy, Front. Aging Neurosci, vol.9, 2017. ,
Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and alpha-synuclein aggregation, Exp. Mol. Med, vol.47, 2015. ,
Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alpha-synuclein processing, Ann. Neurol, vol.69, pp.940-953, 2011. ,
Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies, Cell, vol.146, pp.37-52, 2011. ,
Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage, Neurochem. Int, vol.62, pp.1-7, 2013. ,
Accumulation and distribution of alpha-synuclein and ubiquitin in the CNS of Gaucher disease mouse models, Mol. Genet. Metab, vol.102, pp.436-447, 2011. ,
Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol. Aging, vol.24, pp.197-211, 2002. ,
Transplanted dopaminergic neurons develop PD pathologic changes: A second case report, Mov. Disord, vol.23, pp.2303-2306, 2008. ,
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation, Nat. Med, vol.14, pp.501-503, 2008. ,
Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years, Nat. Med, vol.14, pp.507-509, 2008. ,
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein ,
, Proc. Natl Acad Sci, vol.106, pp.13010-13015, 2009.
Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys, Ann. Neurol, vol.75, pp.351-362, 2014. ,
Exosomes, an Unmasked Culprit in Neurodegenerative Diseases, Front. Neurosci, vol.11, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01490842
Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype, Autophagy, vol.14, pp.98-119, 2018. ,
Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission, Neurobiol. Dis, vol.42, pp.360-367, 2011. ,
Exosomal cell-to-cell transmission of alpha synuclein oligomers, Mol. Neurodegener, vol.7, p.42, 2012. ,
Autophagic failure promotes the exocytosis and intercellular transfer of alpha-synuclein, Exp. Mol. Med, vol.45, 2013. ,
Autophagy modulates SNCA/alpha-synuclein release, thereby generating a hostile microenvironment, Autophagy, vol.10, pp.2171-2192, 2014. ,
ATP13A2/PARK9 regulates secretion of exosomes and alpha-synuclein, J. Neurosci, vol.34, pp.15281-15287, 2014. ,
Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes alpha-Synuclein externalization via exosomes, Hum. Mol. Genet, vol.23, pp.2816-2833, 2014. ,
Glucocerebrosidase depletion enhances cell-to-cell transmission of alpha-synuclein, Nat. Commun, vol.5, 2014. ,
Expression of A53T Mutant But Not Wild-Type ?-Synuclein in PC12 Cells Induces Alterations of the Ubiquitin-Dependent Degradation System, Loss of Dopamine Release, and Autophagic Cell Death, J. Neurosci, vol.21, pp.9549-9560, 2001. ,
HMGB1 is involved in autophagy inhibition caused by SNCA/alpha-synuclein overexpression: A process modulated by the natural autophagy inducer corynoxine B, Autophagy, vol.10, pp.144-154, 2014. ,
alpha-Synuclein impairs macroautophagy: Implications for Parkinson's disease, J. Cell Biol, vol.190, pp.1023-1037, 2010. ,
Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy, PLoS ONE, vol.4, p.5515, 2009. ,
Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy, J. Clin. Invest, vol.118, pp.777-788, 2008. ,
Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose ,
Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy, Science, vol.323, pp.124-127, 2009. ,
Overexpression of Human E46K Mutant ?-Synuclein Impairs Macroautophagy via Inactivation of JNK1-Bcl-2 Pathway, Mol. Neurobiol, vol.50, pp.685-701, 2014. ,
Lewy body-like alpha-synuclein aggregates resist degradation and impair macroautophagy, J. Biol. Chem, vol.288, pp.15194-15210, 2013. ,
Alpha-synuclein induces lysosomal rupture and cathepsin dependent reactive oxygen species following endocytosis, PLoS ONE, vol.8, 2013. ,
Synuclein oligomers distinctively permeabilize complex model membranes, FEBS J, vol.281, pp.2838-2850, 2014. ,
Krainc, D. alpha-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models, Proc. Natl. Acad. Sci, vol.113, pp.1931-1936, 2016. ,
Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases, J. Biol. Chem, vol.286, pp.28080-28088, 2011. ,
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice, Nature, vol.441, pp.885-889, 2006. ,
Loss of autophagy in the central nervous system causes neurodegeneration in mice, Nature, vol.441, pp.880-884, 2006. ,
Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration, Proc. Natl. Acad. Sci, vol.104, pp.14489-14494, 2007. ,
Neuronal lysosomes, Neurosci. Lett, vol.697, pp.1-9, 2019. ,
Role for Rab7 in maturation of late autophagic vacuoles, J. Cell. Sci, vol.117, pp.4837-4848, 2004. ,
Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases, Autophagy, vol.12, pp.472-483, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02439394
alpha-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2, J. Neurosci, vol.35, pp.5724-5742, 2015. ,
Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression, Hum. Mol. Genet, vol.24, pp.6013-6028, 2015. ,
Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice, Proc. Natl. Acad. Sci, vol.107, pp.9879-9884, 2010. ,
Age-Dependent Dopaminergic Neurodegeneration and Impairment of the Autophagy-Lysosomal Pathway in LRRK-Deficient Mice, vol.96, pp.796-807, 2017. ,
Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity, Mol. Brain, vol.1, p.17, 2008. ,
CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy, Proc. Natl. Acad. Sci, vol.108, pp.12101-12106, 2011. ,
Mitochondria in tissue culture, Science, vol.39, pp.330-333, 1914. ,
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants, Proc. Natl. Acad. Sci, vol.100, pp.4078-4083, 2003. ,
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin, Nature, vol.441, pp.1157-1161, 2006. ,
The PINK1/Parkin pathway regulates mitochondrial morphology, Proc. Natl. Acad. Sci, vol.105, pp.1638-1643, 2008. ,
Parkin and PINK1 mutations in early-onset Parkinson's disease: Comprehensive screening in publicly available cases and control, J. Med. Genet, vol.46, pp.375-381, 2009. ,
Mechanisms of mitophagy, Nat. Rev. Mol. Cell Biol, vol.12, pp.9-14, 2011. ,
Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration, Proc. Natl. Acad. Sci, vol.112, pp.11696-11701, 2015. ,
Parkin and PINK1 mitigate STING-induced inflammation, Nature, vol.561, pp.258-262, 2018. ,
Lessons from a Pathway Linked to Parkinson's Disease, Neurotox. Res, 2019. ,
Evidence for a common biological pathway linking three Parkinson's disease-causing genes: Parkin, PINK1 and DJ-1, Eur. J. Neurosci, vol.41, pp.1113-1125, 2015. ,
DJ-1 interactions with alpha-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease ,
DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy, Hum. Mol. Genet, vol.20, pp.40-50, 2011. ,
Essential control of mitochondrial morphology and function by chaperone-mediated autophagy through degradation of PARK7, Autophagy, vol.12, pp.1215-1228, 2016. ,
Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations, Autophagy, vol.15, pp.113-130, 2019. ,
A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease, Am. J. Hum. Genet, vol.89, pp.168-175, 2011. ,
Mutation in VPS35 associated with Parkinson's disease impairs WASH complex association and inhibits autophagy, Nat. Commun, vol.5, 2014. ,
Parkin mediates the ubiquitination of VPS35 and modulates retromer-dependent endosomal sorting, Hum. Mol. Genet, vol.27, pp.3189-3205, 2018. ,
HMGB1 Mediates Autophagy Dysfunction via Perturbing Beclin1-Vps34 Complex in Dopaminergic Cell Model, Front. Mol. Neurosci, vol.10, 2017. ,
Cholesterol and multilamellar bodies: Lysosomal dysfunction in GBA-Parkinson disease, Autophagy, vol.14, pp.717-718, 2018. ,
Acid ceramidase inhibition ameliorates alpha-synuclein accumulation upon loss of GBA1 function, Hum. Mol. Genet, vol.27, 1972. ,
Acid ceramidase and human disease, Biochim. Biophys. Acta, vol.1758, pp.2133-2138, 2006. ,
Lysosome trafficking and signaling in health and neurodegenerative diseases, Neurobiol. Dis, vol.122, pp.94-105, 2019. ,
Rapamycin protects against rotenone-induced apoptosis through autophagy induction, Neuroscience, vol.164, pp.541-551, 2009. ,
Rapamycin improves motor function, reduces 4-hydroxynonenal adducted protein in brain, and attenuates synaptic injury in a mouse model of synucleinopathy, Pathobiol. Aging Age Relat. Dis, vol.5, 2015. ,
Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease, J. Neurosci, vol.30, pp.1166-1175, 2010. ,
TFEB at a glance, J. Cell Sci, vol.129, pp.2475-2481, 2016. ,
Genetic and chemical activation of TFEB mediates clearance of aggregated alpha-synuclein, PLoS ONE, vol.10, 2015. ,
TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity, Proc. Natl. Acad. Sci, vol.110, pp.1817-1826, 2013. ,
Pomegranate activates TFEB to promote autophagy-lysosomal fitness and mitophagy, Sci. Rep, vol.9, 2019. ,
Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy, Cell Rep, vol.13, pp.771-782, 2015. ,
Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia, Nat. Commun, 1562. ,
Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation, Neurobiol. Dis, vol.39, pp.423-438, 2010. ,
Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein, J. Biol. Chem, vol.282, pp.5641-5652, 2007. ,
Chronic Caffeine Treatment Protects Against alpha-Synucleinopathy by Reestablishing Autophagy Activity in the Mouse Striatum, Front. Neurosci, vol.12, 2018. ,
Lithium protects dopaminergic cells from rotenone toxicity via autophagy enhancement, BMC Neurosci, vol.16, 2015. ,
Therapeutic effects of valproate combined with lithium carbonate on MPTP-induced parkinsonism in mice: Possible mediation through enhanced autophagy, Int. J. Neurosci, vol.123, pp.73-79, 2013. ,
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway, Nat. Chem. Biol, vol.4, pp.295-305, 2008. ,
Nilotinib Effects in Parkinson's disease and Dementia with Lewy bodies, J. Parkinsons Dis, vol.6, pp.503-517, 2016. ,
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease, Pharm. Res ,
Presenilin 1 Maintains Lysosomal Ca(2+) Homeostasis via TRPML1 by Regulating vATPase-Mediated Lysosome Acidification, Cell Rep, vol.12, pp.1430-1444, 2015. ,
Harnessing Lysosomal pH through PLGA Nanoemulsion as a Treatment of Lysosomal-Related Neurodegenerative Diseases, Bioconjugate Chem, vol.29, pp.4083-4089, 2018. ,
Lysosomal dysfunction in proteinopathic neurodegenerative disorders: Possible therapeutic roles of cAMP and zinc, Mol. Brain, vol.12, 2019. ,
Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells, Neurobiol. Dis, vol.82, pp.235-242, 2015. ,
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells, Brain, vol.137, pp.1481-1495, 2014. ,
Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: Protocol for a single-centre, randomized, double-blind, placebo-controlled trial, BMC Neurol, 1920. ,
Isorhynchophylline, a natural alkaloid, promotes the degradation of alpha-synuclein in neuronal cells via inducing autophagy, Autophagy, vol.8, pp.98-108, 2012. ,
Beclin1 and HMGB1 ameliorate the alphasynuclein-mediated autophagy inhibition in PC12 cells, Diagn. Pathol, vol.11, 2016. ,
Boosting chaperone-mediated autophagy in vivo mitigates alpha-synuclein-induced neurodegeneration, Brain, vol.136, pp.2130-2146, 2013. ,
Chemical modulation of chaperone-mediated autophagy by retinoic acid derivatives, Nat. Chem. Biol, vol.9, pp.374-382, 2013. ,
DJ-1 expression modulates astrocyte-mediated protection against neuronal oxidative stress, J. Mol. Neurosci, vol.49, pp.507-511, 2013. ,
DJ-1 knock-down in astrocytes impairs astrocyte-mediated neuroprotection against rotenone, Neurobiol. Dis, vol.33, pp.28-36, 2009. ,
DJ-1 deficiency in astrocytes selectively enhances mitochondrial Complex I inhibitor-induced neurotoxicity, J. Neurochem, vol.117, pp.375-387, 2011. ,
Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease, Neurobiol. Dis, vol.115, pp.101-114, 2018. ,
Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease, Pharm. Biochem. Behav, vol.177, pp.1-11, 2019. ,